Jinan Hongyuan Chemical Co.,Ltd
86-13954187575
一. Basic information of taxane anti-tumor drugs
According to the latest statistics of Yaozhi Data, in May 2021, CDE has undertaken a total of 820 new drug registration applications (except f
Time has passed quietly, and 2021 is about to halfw
On December 25, 2020, the Office of the National Medical Security Administration issued the "Notice on Accelerating the Implementation of the Pharmaceutical Price and Recruitment Credit Evaluation Sys
According to the consistency evaluation analysis system of Yaozhi Data Enterprise Edition, 74 new consistency evaluation acceptance numbers we
On May 28, the official website of the Supervision Office of the Shanghai Municipal Health Commission announced the relevant punishment result
Glioma is the most common primary central nervous system tumor. Because it has no obvious boundary with normal brain tissue, it is difficult t
According to incomplete statistics, as of May 31, 54 financing incidents (excluding IPOs, mergers and acquisitions, equity financing, private
"Innovation", as the main driving force of the biomedical industry in recent years, has forced the industry to actively seek technological and
In the past few years, the proportion of targeted drugs in the new drug projects approved by the US FDA has gradually increased, from the comm
On May 26, the international medical journal "The Journal of the American Medical Association" (The Journal of the American Medical Associatio
一. Overview The ASCO annual meeting is known as the "Oscar Ceremony" of international oncology, and the research that is selected for the Oral Abstract Session every year is particula
Since the US FDA approved the first monoclonal antibody OKT3 (muromonab-CD3) in 1986, it has a history of 35 years. Today, antibody drugs acco
Recently, the domestic news on the development of ADC drug research and development has been refreshed
Recently, Shanghai Sunshine Pharmaceutical Purchasing Network issued the "Notice on the Implementation of the Fifth Batch of National-Organize
On May 7, Eimerizumab was approved for the second indication-routine preventive treatment for adults and children with hemophilia A without in
Among the six major pharmaceutical segments in the A-share market, traditional Chinese medicine and pharmaceutical business (pharmaceutical circulation) have been at the lowest valuations for many yea
On May 7, the Director-General of the World Health Organization (WHO) Tan Desai announced that the new coronavirus inactivated vaccine (Vero c
Highlights: In April, CDE added 59 new acceptance numbers (43
Recently, according to the latest report of the IQVIA Institute of Human Data Science, "Outlook 2025: Global Medical Expenditure and Use Trend
Recently, according to Evaluate Pharma data, the Fierce Pharma website released a list of the world’s top 20 drug sales. AbbVie’s Hummer, Merck’s Kerida and Bristol-Myers Squibb’s Rui Fumei ar
On May 4, Pfizer announced its 2021Q1 results. The company's revenue in the first quarter reached US$14.6 billion, an increase of 42% year-on-year. The main driver of the performance was the new crown
Nowadays, foreign multinational pharmaceutical companies have divested their production functions and advocated asset-light operations, which has brought about an increase in the overall outsour
On April 22, Henlius's "Slulimumab injection (ie, recombinant anti-PD-1 humanized monoclonal antibody injection)" was used for unresectable or highly metastatically unresectable or highly metastatic a
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
